SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-040672
Filing Date
2020-08-19
Accepted
2020-08-19 16:01:20
Documents
17
Period of Report
2020-08-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fate-8k_20200817.htm   iXBRL 8-K 55929
2 EX-3.1 fate-ex31_25.htm EX-3.1 4406
3 EX-10.1 fate-ex101_24.htm EX-10.1 29138
4 EX-99.1 fate-ex991_26.htm EX-99.1 16284
5 GRAPHIC gbkugmkmbvmw000001.jpg GRAPHIC 4236
6 GRAPHIC gaalc3tm2d2s000001.jpg GRAPHIC 4465
  Complete submission text file 0001564590-20-040672.txt   271394

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA fate-20200817.xsd EX-101.SCH 5808
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20200817_lab.xml EX-101.LAB 20229
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20200817_pre.xml EX-101.PRE 12108
10 EXTRACTED XBRL INSTANCE DOCUMENT fate-8k_20200817_htm.xml XML 3686
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 201117099
SIC: 2836 Biological Products, (No Diagnostic Substances)